Transactions
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-03 | Hexagon AB | Brett Watson | Member of the Board of Directors | Excercise self-issued instrument | 500 000 | 12,076 | USD | 6 038 000 | 2024-09-02 |
| 2024-09-03 | Hexagon AB | Brett Watson | Member of the Board of Directors | Return of loan increase | 1 500 000 | 0 | USD | 0 | 2024-09-02 |
| 2024-09-03 | Hexagon AB | Brett Watson | Member of the Board of Directors | Exercise decrease | 1 500 000 | 0 | USD | 0 | 2024-09-02 |
| 2024-09-03 | Ascelia Pharma AB | Magnus Olafsson Corfitzen | Chief Executive Officer (CEO)/Managing Directory | Disposal | 112 645 | 0,049 | SEK | 5 565,226 | 2024-08-28 |
| 2024-09-03 | Mycronic AB (publ) | Per Anders Lindqvist | Chief Executive Officer (CEO)/Managing Directory | Allotment | 5 563 | 372,4 | SEK | 2 071 661,2 | 2024-09-01 |
| 2024-09-03 | Mycronic AB (publ) | Per Anders Lindqvist | Chief Executive Officer (CEO)/Managing Directory | Disposal | 3 161 | 374,97 | SEK | 1 185 280,17 | 2024-09-01 |
| 2024-09-03 | Stillfront Group AB (publ) | Jörgen Larsson | Chief Executive Officer (CEO)/Managing Directory | Allotment | 315 000 | 0 | SEK | 0 | 2024-09-02 |
| 2024-09-03 | Mycronic AB (publ) | Clemens Jargon | Other senior executive | Disposal | 943 | 374,97 | SEK | 353 596,71 | 2024-09-01 |
| 2024-09-03 | Mycronic AB (publ) | Clemens Jargon | Other senior executive | Allotment | 2 134 | 372,4 | SEK | 794 701,6 | 2024-09-01 |
| 2024-09-03 | Transferator AB (publ) | Fredrik Vojbacke | Chief Executive Officer (CEO)/Managing Directory | Disposal | 7 000 | 2,53 | SEK | 17 710 | 2024-08-29 |
| 2024-09-03 | Transferator AB (publ) | Fredrik Vojbacke | Chief Executive Officer (CEO)/Managing Directory | Disposal | 1 500 | 2,54 | SEK | 3 810 | 2024-08-29 |
| 2024-09-03 | Resurs Holding AB (publ) | Pia-Lena Olofsson | Member of the Board of Directors | Disposal | 1 876 | 23,5 | SEK | 44 086 | 2024-09-02 |
| 2024-09-03 | Cell Impact AB (publ) | Lars Bergström | Member of the Board of Directors | Acquisition | 500 000 | 0,25 | SEK | 125 215,5 | 2024-09-02 |
| 2024-09-03 | EBLITZ GROUP AB | Lars-Erik Bratt | Chief Executive Officer (CEO)/Managing Directory | Disposal | 1 501 | 1,25 | SEK | 1 876,25 | 2024-08-29 |
| 2024-09-03 | EBLITZ GROUP AB | Lars-Erik Bratt | Chief Executive Officer (CEO)/Managing Directory | Disposal | 63 500 | 1,29 | SEK | 81 915 | 2024-09-01 |
| 2024-09-03 | Swedish Orphan Biovitrum AB | Katy Mazibuko | Employee Representative of the Board of Directors or deputy Employee Representative of the Board of Directors | Disposal | 1 500 | 320 | SEK | 480 000 | 2024-08-29 |
| 2024-09-03 | Swedish Orphan Biovitrum AB (publ) | Katy Mazibuko | Employee Representative of the Board of Directors or deputy Employee Representative of the Board of Directors | Disposal | 269 | 319,75 | SEK | 86 012,75 | 2024-08-29 |
| 2024-09-03 | Getinge AB | Dan Frohm | Member of the Board of Directors | Acquisition | 2 300 | 217,581 | SEK | 500 436,3 | 2024-09-02 |
| 2024-09-03 | Agtira AB | Ludvig Nauckhoff | Chairman of the Board of Directors | Allotment | 75 000 | 0,68 | SEK | 51 000 | 2024-08-30 |
| 2024-09-04 | Dicot Pharma AB | Fredrik Buch | Member of the Board of Directors | Subscription | 179 291 | 1,2 | SEK | 215 149,2 | 2024-09-01 |